Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 25 Apr 2025

Long non-coding rnas as key modulators of the immune microenvironment in hepatocellular carcinoma: implications for Immunotherapy

in Cancer Immunity and Immunotherapy

Siqi Zhao
Fei Chen
Lingyu Hu
Xiaoping Li
Zhaofeng Gao
Minjie Chen
Xiaoguang Wang
Zhengwei Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1523190

Review

Published on 25 Apr 2025

Discovery of drug transporter inhibitors tied to long noncoding RNA in resistant cancer cells; a computational model -in silico- study

in Cancer Immunity and Immunotherapy

Mohanad Diab
Amel Hamdi
Feras Al-Obeidat
Wael Hafez
Ivan Cherrez-Ojeda
Muneir Gador
Gowhar Rashid
Sana F. Elkhazin
Mahmad Anwar Ibrahim
Tarek Farag Ismail

Frontiers in Immunology

doi 10.3389/fimmu.2025.1511029

146 views

Original Research

Published on 25 Apr 2025

A predictive model for the transformation from cervical inflammation to cancer based on tumor immune-related factors

in Cancer Immunity and Immunotherapy

Wenjie Wang
Chuntao Huang
Shiwen Bi
Huiting Liang
Songlin Li
Tingting Lu
Ben Liu
Yong Tang
Qi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532048

104 views

Systematic Review

Published on 25 Apr 2025

Bispecific antibodies combined with chemotherapy in solid tumor treatment, the path forward?

in Cancer Immunity and Immunotherapy

Yici Yan
Jing Yuan
Yanyang Peng
Chenxi Zhou
Xinbo Liu
Leitao Sun
Qiaoling Song

Frontiers in Immunology

doi 10.3389/fimmu.2025.1568724

Original Research

Published on 25 Apr 2025

The miR-941/FOXN4/TGF-β feedback loop induces N2 polarization of neutrophils and enhances tumor progression of lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Xiaojing Zhang
Xitong Huang
Xianying Zhang
Lichang Lai
Baoyi Zhu
Peibin Lin
Zhanfang Kang
Dazhong Yin
Dongbo Tian
Zisheng Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1561081

Review

Published on 25 Apr 2025

Oncolytic viruses: a promising therapy for malignant pleural effusion and solid tumors

in Cancer Immunity and Immunotherapy

Xinya Wang
Qin Zhou
Xuyan Zhang
Han Hu
Binlei Liu
Yang Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1570698

313 views

Review

Published on 25 Apr 2025

From neglect to necessity: the role of innate immunity in cutaneous squamous cell carcinoma therapy

in Cancer Immunity and Immunotherapy

Yong He
Ting Tian
Yuancheng Li
Yong Zeng
Xiaoke Wang
Leqi Qian
Tian Tian
Mingjun Jiang
Liming Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1570032

Original Research

Published on 25 Apr 2025

In vivo RNAi screen and validation reveals Ngp, Hba-a1, and S100a8 as novel inhibitory targets on T lymphocytes in liver cancer

in Cancer Immunity and Immunotherapy

Inga Hochnadel
Lisa Hoenicke
Nataliia Petriv
Huizhen Suo
Lothar Groebe
Chantal Olijnik
Nina Bondarenko
Juan C. Alfonso
Michael Jarek
Ruibing Shi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1549229

189 views

Systematic Review

Published on 25 Apr 2025

Effectiveness and safety of teclistamab for relapsed or refractory multiple myeloma: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Wenze Li
Defeng Zhao
Yu Jiao
Weilin Dong
Ziyi Wang
Xiaojing Yan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1565407

211 views

Original Research

Accepted on 24 Apr 2025

Effect of bispecific recombinant oncolytic adenovirus carrying apoptin on apoptosis of MCF-7 cells

in Cancer Immunity and Immunotherapy

Shuang Chen
Wenyao Li
Xunzhe Yin
Cheng Hu
Yiquan Li
Xiaotong Shao
Xiao Li
Ningyi Jin

Frontiers in Immunology

doi 10.3389/fimmu.2025.1530583

Original Research

Accepted on 24 Apr 2025

TSPAN4⁺ Fibroblasts Coordinate Metastatic Niche Assembly Through Migrasome-Driven Metabolic Reprogramming and Stromal-Immune Crosstalk in Pancreatic Adenocarcinoma

in Cancer Immunity and Immunotherapy

Qingwen Hu
Jiali Chen
Yang Liu
Haiqing Chen
Haotian Lai
Lai Jiang
Xuancheng Zhou
Shengke Zhang
Jinbang Huang
Hao Chi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1594879

Original Research

Accepted on 24 Apr 2025

Lung Microbiome Alterations Correlate with Immune Imbalance in Non-Small Cell Lung Cancer

in Cancer Immunity and Immunotherapy

Jiuling Cheng
Huaqi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1589843

Review

Accepted on 24 Apr 2025

Tumor-infiltrating immune cells stateimplications for various breast cancer subtypes

in Cancer Immunity and Immunotherapy

Tianshuang Xu
Hongjun Zhang
Javeria Qadir
Hui Yuan
Ting Ye

Frontiers in Immunology

doi 10.3389/fimmu.2025.1550003

Editorial

Accepted on 24 Apr 2025

EDITORIAL: Innate Immune Pathways as Targets for Developing Therapeu9c Interven9on against Human Cancers

in Cancer Immunity and Immunotherapy

Fabio Grizzi
Miguel Martin-Perez
Geeta Rai
Abdullah Saeed
Ayush Raman
Devivasha Bordoloi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1595279

Review

Accepted on 24 Apr 2025

Predictive Biomarkers in the Era of Immunotherapy for Gastric Cancer: Current Achievements and Future Perspectives Author

in Cancer Immunity and Immunotherapy

Fujing Sun
Yanmei Zhu
Xiaozhuo Gao
Wentao Wang
Xiaoyan Zhao
Jingdong Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1599908

Original Research

Accepted on 24 Apr 2025

Integrated Multi-Omics Profiling to Establish an IGFBP-Based Prognostic Score for Pancreatic Ductal Adenocarcinoma: Unraveling Prognostic Biomarkers, Immune Microenvironment Crosstalk, and Therapeutic Implications

in Cancer Immunity and Immunotherapy

Yongrun Mu
Xiao Guan
Xin Jin
Chengfeng Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1600527